Assessment | Duloxetine/Duloxetine (n= 176) | Placebo/Duloxetine (n= 187) | ||
---|---|---|---|---|
 | Baseline mean (SD) | Mean change (SE) | Baseline mean (SD) | Mean change (SE) |
Multidimensional Fatigue Inventory | Â | Â | Â | Â |
   General Fatigue | 14.6 (3.8) | -0.61 (0.3)a | 15.5 (3.7) | -1.02 (0.3)a |
   Mental Fatigue | 13.1 (3.9) | -0.43 (0.3) | 13.8 (4.2) | -0.32 (0.3) |
   Physical Fatigue | 10.6 (4.1) | -0.41 (0.2) | 11.7 (4.3) | -0.51 (0.2)a |
   Reduced Activity | 11.9 (4.3) | -0.29 (0.3) | 12.8 (4.2) | -0.64 (0.3)a |
   Reduced Motivation | 10.2 (3.9) | -0.71 (0.3)a | 11.2 (3.8) | -0.49 (0.3) |
BPI average pain | 4.1 (2.3) | -0.56 (0.2)a | 4.9 (2.4) | -0.66 (0.2)a |
Anxiety | 2.2 (2.5) | -0.43 (0.2)a | 3.1 (2.8) | -0.45 (0.2)a |
Mood | 2.2 (2.6) | -0.54 (0.2)a | 3.1 (2.7) | -0.83 (0.2)a |
Sleep difficulties | 4.6 (3.1) | -0.81 (0.2)a | 5.1 (2.9) | -1.12 (0.2)a |
Stiffness | 4.4 (2.7) | -0.67 (0.2)a | 5.2 (2.7) | -0.82 (0.2)a |